메뉴 건너뛰기




Volumn 30, Issue 8, 2012, Pages 1581-1586

Concise review: The role of hematopoietic stem cell transplantation in the treatment of acute myeloid leukemia

Author keywords

Acute myelogenous leukemia; Adult hematopoietic stem cells leukemia; Hematopoietic stem cell transplantation

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER GENETICS; CANCER STEM CELL; CYTOGENETICS; HUMAN; OUTCOMES RESEARCH; PATIENT SELECTION; REVIEW; RISK ASSESSMENT; TREATMENT INDICATION;

EID: 84864338677     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1140     Document Type: Review
Times cited : (44)

References (58)
  • 1
    • 79953700536 scopus 로고    scopus 로고
    • The EBMT activity survey 2009: Trends over the past 5 years
    • Bladomero H, Gratwohl M, Gratwohl A et al. The EBMT activity survey 2009: Trends over the past 5 years. Bone Marrow Transplant 2011;46:485-501.
    • (2011) Bone Marrow Transplant , vol.46 , pp. 485-501
    • Bladomero, H.1    Gratwohl, M.2    Gratwohl, A.3
  • 3
    • 33646119401 scopus 로고    scopus 로고
    • Hematopoietic stem-cell transplantation
    • Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006;354:1813-1826.
    • (2006) N Engl J Med , vol.354 , pp. 1813-1826
    • Copelan, E.A.1
  • 4
    • 78649429727 scopus 로고    scopus 로고
    • Reduced mortality after allogeneic hematopoietic-cell transplantation
    • Gooley TA, Chien JW, Pergam SA et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010;363: 2091-2101.
    • (2010) N Engl J Med , vol.363 , pp. 2091-2101
    • Gooley, T.A.1    Chien, J.W.2    Pergam, S.A.3
  • 5
    • 16844368698 scopus 로고    scopus 로고
    • Tumour stem cells and drug resistance
    • DOI 10.1038/nrc1590
    • Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005;5:275-284. (Pubitemid 40488633)
    • (2005) Nature Reviews Cancer , vol.5 , Issue.4 , pp. 275-284
    • Dean, M.1    Fojo, T.2    Bates, S.3
  • 6
    • 84859854912 scopus 로고    scopus 로고
    • A clinically relevant population of leukemia CD34+CD38- cells in acute myeloid leukemia
    • Gerber JM, Smith BD, Ngwang B et al. A clinically relevant population of leukemia CD34+CD38- cells in acute myeloid leukemia. Blood 2012;119:3571-3577.
    • (2012) Blood , vol.119 , pp. 3571-3577
    • Gerber, J.M.1    Smith, B.D.2    Ngwang, B.3
  • 7
    • 2142708323 scopus 로고    scopus 로고
    • Meta-analysis of autologous bone marrow transplantation versus chemotherapy in adult patients with acute myeloid leukemia in first remission
    • DOI 10.1016/j.leukres.2003.10.029, PII S0145212603003928
    • Levi I, Grotto I, Yerushalmi R et al. Meta-analysis of autologous bone marrow transplantation versus chemotherapy in adult patients with acute myeloid leukemia in first remission. Leukemia Res 2004;28:605-612. (Pubitemid 38543197)
    • (2004) Leukemia Research , vol.28 , Issue.6 , pp. 605-612
    • Levi, I.1    Grotto, I.2    Yerushalmi, R.3    Ben-Bassat, I.4    Shpilberg, O.5
  • 8
    • 84862776906 scopus 로고    scopus 로고
    • Clonal evaluation in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
    • Ding L, Ley TJ, Larson DE et al. Clonal evaluation in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012;481:506-510.
    • (2012) Nature , vol.481 , pp. 506-510
    • Ding, L.1    Ley, T.J.2    Larson, D.E.3
  • 9
    • 0029796633 scopus 로고    scopus 로고
    • Long-term lymphohematopoietic reconstitution by a single CD34- low/negative hematopoietic stem cell
    • Osawa M, Hanada K, Hamada H et al. Long term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996;273:242-245. (Pubitemid 26285891)
    • (1996) Science , vol.273 , Issue.5272 , pp. 242-245
    • Osawa, M.1    Hanada, K.-I.2    Hamada, H.3    Nakauchi, H.4
  • 10
    • 0000448725 scopus 로고
    • Modification of irradiation injury in mice and guinea pigs by bone marrow injections
    • Lorenze E, Uphoff D, Reid TR et al. Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 1951;12:197-201.
    • (1951) J Natl Cancer Inst , vol.12 , pp. 197-201
    • Lorenze, E.1    Uphoff, D.2    Reid, T.R.3
  • 11
    • 0014748313 scopus 로고
    • Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow transplantation
    • Storb R, Epstein RB, Graham TC et al. Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow transplantation. Blood Transplantation 1970;9:240-246.
    • (1970) Blood Transplantation , vol.9 , pp. 240-246
    • Storb, R.1    Epstein, R.B.2    Graham, T.C.3
  • 12
    • 0017581598 scopus 로고
    • One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogenic marrow transplantation
    • Thomas ED, Buckner CD, Banaji M et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 1977;49:511-533. (Pubitemid 8080182)
    • (1977) Blood , vol.49 , Issue.4 , pp. 511-533
    • Thomas, E.D.1    Buckner, C.D.2    Banaji, M.3
  • 13
    • 0018719188 scopus 로고
    • Marrow transplantation for acute nonlymphoblastic leukemia in first remission
    • Thomas ED, Buckner CD, Clift RA et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med 1979;301:597-599. (Pubitemid 10226458)
    • (1979) New England Journal of Medicine , vol.301 , Issue.11 , pp. 597-599
    • Thomas, E.D.1    Buckner, C.D.2    Clift, R.A.3
  • 15
    • 39649115845 scopus 로고    scopus 로고
    • Hematopoietic cell transplantation-specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: Combined FHCRC and MDACC experiences
    • DOI 10.1182/blood-2007-06-096966
    • Sorror ML, Giralt S, Sandmaier BM et al. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: Combined FHCRC and MDACC experiences. Blood 2007;110:4606-4613. (Pubitemid 351377830)
    • (2007) Blood , vol.110 , Issue.13 , pp. 4606-4613
    • Sorror, M.L.1    Giralt, S.2    Sandmaier, B.M.3    De Lima, M.4    Shahjahan, M.5    Maloney, D.G.6    Deeg, H.J.7    Appelbaum, F.R.8    Storer, B.9    Storb, R.10
  • 16
    • 67349250764 scopus 로고    scopus 로고
    • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or nonmyeloablative allogeneic stem cell transplantation
    • Farina L, Bruno B, Patriarca F et al. The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or nonmyeloablative allogeneic stem cell transplantation. Leukemia 2009;23:1131-1138.
    • (2009) Leukemia , vol.23 , pp. 1131-1138
    • Farina, L.1    Bruno, B.2    Patriarca, F.3
  • 17
    • 77950630112 scopus 로고    scopus 로고
    • Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML
    • Lim ZY, Ingram W, Brand R et al. Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML. Bone Marrow Transplant 2010;45:633-639.
    • (2010) Bone Marrow Transplant , vol.45 , pp. 633-639
    • Lim, Z.Y.1    Ingram, W.2    Brand, R.3
  • 18
    • 41949142667 scopus 로고    scopus 로고
    • Hematopoietic Stem Cell Transplantation in Adults with Acute Myeloid Leukemia
    • DOI 10.1016/j.bbmt.2008.02.019, PII S1083879108001080
    • Hamadani M, Awan FT, Copelan EA. Hematopoietic stem cell transplantation in adults with acute myeloid leukemia. Biol Blood Marrow Transplant 2008;14:556-567. (Pubitemid 351505928)
    • (2008) Biology of Blood and Marrow Transplantation , vol.14 , Issue.5 , pp. 556-567
    • Hamadani, M.1    Awan, F.T.2    Copelan, E.A.3
  • 19
    • 67049164836 scopus 로고    scopus 로고
    • Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: Systematic review and metaanalysis of prospective clinical trials
    • Koreth J, Schlenk R, Kopecky KJ et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: Systematic review and metaanalysis of prospective clinical trials. JAMA 2009;301:2349-2361.
    • (2009) JAMA , vol.301 , pp. 2349-2361
    • Koreth, J.1    Schlenk, R.2    Kopecky, K.J.3
  • 20
    • 24944464648 scopus 로고    scopus 로고
    • Prognostic factors and out-come of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients from inv(16): A Cancer and Leukemia Group B study
    • Marcucci G, Mrozek K, Ruppert AS et al. Prognostic factors and out-come of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients from inv(16): A Cancer and Leukemia Group B study. J Clin Oncol 2005;23:5705-5717.
    • (2005) J Clin Oncol , vol.23 , pp. 5705-5717
    • Marcucci, G.1    Mrozek, K.2    Ruppert, A.S.3
  • 23
    • 16844374525 scopus 로고    scopus 로고
    • Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: A metaanalysis
    • DOI 10.1002/cncr.20945
    • Yanada M, Matsuo K, Emi N et al. Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: A metaanalysis. Cancer 2005;103:1652-1658. (Pubitemid 40490026)
    • (2005) Cancer , vol.103 , Issue.8 , pp. 1652-1658
    • Yanada, M.1    Matsuo, K.2    Emi, N.3    Naoe, T.4
  • 24
    • 77957715843 scopus 로고    scopus 로고
    • Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: The Southwest Oncology Group (SWOG) experience
    • Medeiros BC, Othus M, Fang M et al. Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: The Southwest Oncology Group (SWOG) experience. Blood 2010;116:2224-2228.
    • (2010) Blood , vol.116 , pp. 2224-2228
    • Medeiros, B.C.1    Othus, M.2    Fang, M.3
  • 25
    • 80051609304 scopus 로고    scopus 로고
    • Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation
    • Fang M, Storer B, Estey E et al. Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation. Blood 2011;118:1490-1494.
    • (2011) Blood , vol.118 , pp. 1490-1494
    • Fang, M.1    Storer, B.2    Estey, E.3
  • 26
    • 0035885955 scopus 로고    scopus 로고
    • The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
    • Kottardis PD, Gale RE, Frew ME et al. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 2001;98:1752-1759.
    • (2001) Blood , vol.98 , pp. 1752-1759
    • Kottardis, P.D.1    Gale, R.E.2    Frew, M.E.3
  • 27
    • 67650351086 scopus 로고    scopus 로고
    • Structural and functional alterations of FLT3 in acute myeloid leukemia
    • Meshinchi S, Appelbaum FR. Structural and functional alterations of FLT3 in acute myeloid leukemia. Clin Cancer Res 2009;15:4263-4269.
    • (2009) Clin Cancer Res , vol.15 , pp. 4263-4269
    • Meshinchi, S.1    Appelbaum, F.R.2
  • 28
    • 33646557337 scopus 로고    scopus 로고
    • Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
    • DOI 10.1182/blood-2005-08-3167
    • Thiede C, Koch S, Creutzig E et al. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood 2006;107:4011-4020. (Pubitemid 43726809)
    • (2006) Blood , vol.107 , Issue.10 , pp. 4011-4020
    • Thiede, C.1    Koch, S.2    Creutzig, E.3    Steudel, C.4    Illmer, T.5    Schaich, M.6    Ehninger, G.7
  • 30
    • 77955907891 scopus 로고    scopus 로고
    • IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication
    • Paschka P, Schlenk RF, Gaidzik VI et al. IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication. J Clin Oncol 2010;28:3636-3643.
    • (2010) J Clin Oncol , vol.28 , pp. 3636-3643
    • Paschka, P.1    Schlenk, R.F.2    Gaidzik, V.I.3
  • 31
    • 78649906060 scopus 로고    scopus 로고
    • DNMT3A mutations in acute myeloid leukemia
    • Ley TJ, Ding L, Walter MJ et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010;363:2424-2433.
    • (2010) N Engl J Med , vol.363 , pp. 2424-2433
    • Ley, T.J.1    Ding, L.2    Walter, M.J.3
  • 32
    • 84863393263 scopus 로고    scopus 로고
    • Prognostic relevance of integrated genetic profiling in acute myeloid leukemia
    • Patel J, Gonen M, Figueroa M et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012;366:1079-1089.
    • (2012) N Engl J Med , vol.366 , pp. 1079-1089
    • Patel, J.1    Gonen, M.2    Figueroa, M.3
  • 33
    • 79955973367 scopus 로고    scopus 로고
    • Integrative prognostic risk score in acute myeloid leukemia with normal karyotype
    • Damm F, Heuser M, Morgan M et al. Integrative prognostic risk score in acute myeloid leukemia with normal karyotype. Blood 2011;117:4561-4568.
    • (2011) Blood , vol.117 , pp. 4561-4568
    • Damm, F.1    Heuser, M.2    Morgan, M.3
  • 34
    • 0742324488 scopus 로고    scopus 로고
    • Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): An analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML
    • DOI 10.1038/sj.leu.2403187
    • Schoch C, Kern W, Schnittger S et al. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): An analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia 2004;18:120-125. (Pubitemid 38159447)
    • (2004) Leukemia , vol.18 , Issue.1 , pp. 120-125
    • Schoch, C.1    Kern, W.2    Schnittger, S.3    Hiddemann, W.4    Haferlach, T.5
  • 37
    • 77957278020 scopus 로고    scopus 로고
    • Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure
    • Duval M, Klein JP, He W et al. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol 2010;28:3730-3738.
    • (2010) J Clin Oncol , vol.28 , pp. 3730-3738
    • Duval, M.1    Klein, J.P.2    He, W.3
  • 40
    • 77950317460 scopus 로고    scopus 로고
    • 50 Years of allogeneic bone-marrow transplantation
    • Powles R. 50 years of allogeneic bone-marrow transplantation. Lancet Oncol 2010;11:305-306.
    • (2010) Lancet Oncol , vol.11 , pp. 305-306
    • Powles, R.1
  • 41
    • 84858664378 scopus 로고    scopus 로고
    • Increased incidence of chronic graft versus host disease (GVHD) and no survival advantage with Filgastrim-mobilized peripheral blood stem cells (PBSC) compared to bone marrow (BM) transplants from unrelated donors: Results of Blood and Marrow Transplant Clincal Trails Network (BMT CTN) Protocol 0201, a Phase III, Prospective Randomized Trial
    • abstract 1
    • Anasetti C, Logan BR, Lee SJ et al. Increased incidence of chronic graft versus host disease (GVHD) and no survival advantage with Filgastrim-mobilized peripheral blood stem cells (PBSC) compared to bone marrow (BM) transplants from unrelated donors: Results of Blood and Marrow Transplant Clincal Trails Network (BMT CTN) Protocol 0201, a Phase III, Prospective Randomized Trial. Blood 2011;118:abstract 1.
    • (2011) Blood , vol.118
    • Anasetti, C.1    Logan, B.R.2    Lee, S.J.3
  • 42
    • 84863414080 scopus 로고    scopus 로고
    • Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow
    • Mielcarek M, Storer B, Martin PJ et al. Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow. Blood 2010;119:2675-2678.
    • (2010) Blood , vol.119 , pp. 2675-2678
    • Mielcarek, M.1    Storer, B.2    Martin, P.J.3
  • 43
    • 77956931642 scopus 로고    scopus 로고
    • Comparable survival after HLA-well matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis
    • Gupta V, Tallman MS, He W et al. Comparable survival after HLA-well matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood 2010;116:1839-1848.
    • (2010) Blood , vol.116 , pp. 1839-1848
    • Gupta, V.1    Tallman, M.S.2    He, W.3
  • 44
    • 84860342455 scopus 로고    scopus 로고
    • Outcomes after matched unrelated donor vs. identical sibling hematopoietic cell transplantation (HCT) in adults with acute myelogenous leukemia (AML)
    • Saber W, Opie S, Rizzo JD et al. Outcomes after matched unrelated donor vs. identical sibling hematopoietic cell transplantation (HCT) in adults with acute myelogenous leukemia (AML). Blood 2012;119:3908-3916.
    • (2012) Blood , vol.119 , pp. 3908-3916
    • Saber, W.1    Opie, S.2    Rizzo, J.D.3
  • 47
    • 77954031042 scopus 로고    scopus 로고
    • Effect of graft source of unrelated donor hematopoietic stem-cell transplantation in adults with acute leukemia: A retrospective analysis
    • Eapen M, Rocha V, Sanz G et al. Effect of graft source of unrelated donor hematopoietic stem-cell transplantation in adults with acute leukemia: A retrospective analysis. Lancet 2010;11:653-660.
    • (2010) Lancet , vol.11 , pp. 653-660
    • Eapen, M.1    Rocha, V.2    Sanz, G.3
  • 48
    • 78649462137 scopus 로고    scopus 로고
    • Allogeneic hematopoietic cell transplantation for hematologic malignancy: Relative risks and benefits of double umbilical cord blood
    • Brunstein CG, Gutman JA, Weisdorf DJ et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: Relative risks and benefits of double umbilical cord blood. Blood 2010;116:4693-99.
    • (2010) Blood , vol.116 , pp. 4693-4699
    • Brunstein, C.G.1    Gutman, J.A.2    Weisdorf, D.J.3
  • 51
    • 0035895063 scopus 로고    scopus 로고
    • Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: Long-term follow-up of 4 randomized studies
    • Socie G, Clift RA, Blaise D et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: Long-term follow-up of 4 randomized studies. Blood 2001;98:3569-3574.
    • (2001) Blood , vol.98 , pp. 3569-3574
    • Socie, G.1    Clift, R.A.2    Blaise, D.3
  • 52
    • 10044284478 scopus 로고    scopus 로고
    • Nonmyeloablative therapy and hematopoietic cell transplantation for hematologic disorders
    • Blume KG, Forman SJ, Appelbaum FR, eds. 3rd ed. Malden, MA: Blackwell Publishing
    • Sandmaier BM, Storb R. Nonmyeloablative therapy and hematopoietic cell transplantation for hematologic disorders. In: Blume KG, Forman SJ, Appelbaum FR, eds. Thomas' Hematopoietic Cell Transplantation. 3rd ed. Malden, MA: Blackwell Publishing, 2004:1164-1176.
    • (2004) Thomas' Hematopoietic Cell Transplantation , pp. 1164-1176
    • Sandmaier, B.M.1    Storb, R.2
  • 53
    • 84857030601 scopus 로고    scopus 로고
    • Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS
    • Luger SM, Ringden O, Zhang MJ et al. Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Bone Marrow Transplant 2012;47:203-211.
    • (2012) Bone Marrow Transplant , vol.47 , pp. 203-211
    • Luger, S.M.1    Ringden, O.2    Zhang, M.J.3
  • 54
    • 80053021436 scopus 로고    scopus 로고
    • Preparative regimens and ageism
    • Appelbaum F. Preparative regimens and ageism. Biol Blood Marrow Transplant 2011;17:1419-1420.
    • (2011) Biol Blood Marrow Transplant , vol.17 , pp. 1419-1420
    • Appelbaum, F.1
  • 55
    • 80052576601 scopus 로고    scopus 로고
    • Myeloablative, reduced toxicity IV busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients in the sixth through eighth decades of life
    • Alatrash G, de Lima M, Hamerschlak N et al. Myeloablative, reduced toxicity IV busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients in the sixth through eighth decades of life. Biol Blood Marrow Transplant 2011;17:1490-1496.
    • (2011) Biol Blood Marrow Transplant , vol.17 , pp. 1490-1496
    • Alatrash, G.1    De Lima, M.2    Hamerschlak, N.3
  • 57
    • 81255211516 scopus 로고    scopus 로고
    • Reduced-intensity allogeneic hematopoietic transplantation should be considered a standard of care for older patients with acute myeloid leukemia
    • Champlin R. Reduced-intensity allogeneic hematopoietic transplantation should be considered a standard of care for older patients with acute myeloid leukemia. Biol Blood Marrow Transplant 2011;17:1721-1724.
    • (2011) Biol Blood Marrow Transplant , vol.17 , pp. 1721-1724
    • Champlin, R.1
  • 58
    • 68049118980 scopus 로고    scopus 로고
    • Loss of mismatched HLA in leukemia after stem-cell transplantation
    • Vago L, Perna SK, Zanussi M et al. Loss of mismatched HLA in leukemia after stem-cell transplantation. N Engl J Med 2009;361:478-488.
    • (2009) N Engl J Med , vol.361 , pp. 478-488
    • Vago, L.1    Perna, S.K.2    Zanussi, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.